13F reference period
Q2 2026
Security Snapshot
ENDRA Life Sciences Inc. - Common Stock, par value $0.0001 per share (NDRA) Institutional Ownership
CUSIP: 29273B500
13F Institutional Holders and Ownership History from Q4 2024 to Q2 2026
Institutions Reporting
10
Shares (Excl. Options)
153,657
Price
$5.33
The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Symbol
- NDRA on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 153,657
- Total 13F value
- $818,991
- Portfolio coverage rank
- 0%
- Share change
- +64,021
- Value change
- +$341,236
- Number of holders
- 10
- Shares outstanding
- 1,682,219
- SEC-reported price per share
- $6.46
- Insider filing price
- $6.46
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- NDRA - ENDRA Life Sciences Inc. - Common Stock, par value $0.0001 per share is tracked under CUSIP 29273B500.
- 10 institutions reported positions in Q2 2026.
- 1 significant owner is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 8 to 10 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $416,807 to $818,991.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 10 institutions filings for Q2 2026.
Security key
29273B500
13F reference period
Q2 2026
13F holders
10
13D/G owners
1
CIK / CUSIP context first
Open Q2 2026 holders
NDRA full holder history
ENDRA Life Sciences Inc. SEC filings
ENDRA Life Sciences Inc. company facts
ENDRA Life Sciences Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 29273B500:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
1
Security
NDRA
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| ASP Isotopes Inc. | 15% | $1,640,937 | 254,015 | ASP Isotopes Inc. | 01 Oct 2026 |
As of 30 Jun 2026, 10 institutional investors reported holding 153,657 shares of ENDRA Life Sciences Inc. - Common Stock, par value $0.0001 per share (NDRA). This represents 9.1% of the company’s total 1,682,219 outstanding shares.
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
7
Headline period
Q2 2026
Rows shown
1-7 of 7
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 153,657 | $818,991 | +$341,236 | $5.33 | 10 |
| 2026 Q1 | 89,636 | $416,807 | +$82,822 | $4.65 | 8 |
| 2025 Q4 | 71,825 | $325,366 | +$255,093 | $4.53 | 7 |
| 2025 Q3 | 13,086 | $70,401 | +$44,934 | $5.38 | 5 |
| 2025 Q2 | 4,736 | $16,623 | +$11,976 | $3.51 | 3 |
| 2025 Q1 | 1,134 | $4,649 | +$3,957 | $4.05 | 2 |
| 2024 Q4 | 112 | $701 | +$701 | $6.25 | 3 |